{"id":170918,"date":"2025-09-04T04:25:51","date_gmt":"2025-09-04T08:25:51","guid":{"rendered":"https:\/\/44.250.171.167\/?p=170918"},"modified":"2025-09-04T04:25:51","modified_gmt":"2025-09-04T08:25:51","slug":"blue-jet-healthcare-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/blue-jet-healthcare-q1-fy26-earnings-results\/","title":{"rendered":"Blue Jet Healthcare Q1 FY26 Earnings Results"},"content":{"rendered":"<p>Blue Jet Healthcare Ltd, incorporated in 1968 (formerly Jet Chemicals Pvt Ltd), is a prominent pharmaceutical and healthcare ingredients company in India and was the first manufacturer of saccharin and its salts (artificial sweeteners) in the country. The company operates in multiple segments including contrast media intermediates, high-intensity sweeteners, and pharma intermediates &amp; APIs. Presenting below its Q1 FY26 Earnings Results.<\/p>\n<h2><strong>Q1 FY26 Financial Highlights<\/strong><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> \u20b9354.8 crore, showing a robust growth of 117.8% year-on-year, driven primarily by strong sales in pharma intermediates and API product categories.<\/li>\n<li><strong>EBITDA:<\/strong> \u20b9121 crore, up 173.3% YoY, though down 13.6% quarter-on-quarter, with the EBITDA margin at 34.1%, reflecting a boost from operational efficiency but impacted by a drop in gross margin compared to the previous quarter.<\/li>\n<li><strong><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/b95533b7-cc6e-47a9-8d48-6e06daa8efd1.pdf\" target=\"_blank\" rel=\"noopener\">Net Profit (PAT):<\/a><\/strong> \u20b991.2 crore, a 141.3% increase YoY but decreased 17.2% QoQ, with a PAT margin of 25.7%.<\/li>\n<li><strong>Gross Margin:<\/strong> Declined to 48.4% in Q1 FY26 from 54.7% in Q4 FY25, impacted by product mix shifts and lower inventory levels.<\/li>\n<li><strong>Earnings per Share:<\/strong> \u20b95.3, more than doubling compared to the previous year.<\/li>\n<\/ul>\n<h2><strong>Operational Highlights and Strategic Insights<\/strong><\/h2>\n<ul>\n<li>The significant YoY growth reflects the company\u2019s strong foothold in pharma intermediates and APIs, emphasizing its focus on high-value products.<\/li>\n<li>Quarterly decline in margins and profits is attributed to a shift in product mix and reduced inventory absorption, causing a temporary dip in profitability.<\/li>\n<li>Blue Jet Healthcare continues to invest in capacity expansion and R&amp;D capabilities to sustain long-term growth and develop a robust pipeline of innovative products.<\/li>\n<li>The management remains confident in delivering consistent performance backed by strategic investments and innovation.<\/li>\n<li><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-170919\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET.png\" alt=\"BLUEJET Q1 FY26 Earnings Results\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/li>\n<\/ul>\n<h2><strong>Outlook<\/strong><\/h2>\n<p>Blue Jet Healthcare Ltd is well-positioned for sustainable growth with a focus on expanding manufacturing capacity, enhancing product portfolio, and driving innovation. While short-term margin pressures persist due to product mix changes, the company\u2019s long-term fundamentals and growth prospects remain strong.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts,<a href=\"https:\/\/44.250.171.167\/symbol\/bluejet\/\"> click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Blue Jet Healthcare Ltd, incorporated in 1968 (formerly Jet Chemicals Pvt Ltd), is a prominent pharmaceutical and healthcare ingredients company in India and was the first manufacturer of saccharin and its salts (artificial sweeteners) in the country. The company operates in multiple segments including contrast media intermediates, high-intensity sweeteners, and pharma intermediates &amp; APIs. Presenting [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":170919,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[13743],"class_list":["post-170918","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-health-care"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BLUEJET.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":180678,"url":"https:\/\/alphastreet.com\/india\/blue-jet-healthcare-strengthens-specialty-capacity-amid-q3-market-volatility\/","url_meta":{"origin":170918,"position":0},"title":"Blue Jet Healthcare Strengthens Specialty Capacity Amid Q3 Market Volatility","author":"Staff Correspondant","date":"February 13, 2026","format":false,"excerpt":"Blue Jet Healthcare Ltd (BSE: BLUEJET), with a market capitalization of ~\u20b97,650\u202fCr, is a Mumbai-based specialty pharmaceutical and healthcare ingredient manufacturer. The company produces pharmaceutical intermediates, APIs, contrast media intermediates, and high-intensity sweeteners. Its customers include hospitals, FMCG, agrochemical clients, and global contrast media manufacturers. The company operates across three\u2026","rel":"","context":"In &quot;LATEST&quot;","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":170447,"url":"https:\/\/alphastreet.com\/india\/aarti-drugs-q1-fy26-earnings-results\/","url_meta":{"origin":170918,"position":1},"title":"Aarti Drugs Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 21, 2025","format":false,"excerpt":"Aarti Drugs Ltd, established in 1984 and part of the $1000 million Aarti Group of Industries, is engaged in manufacturing and selling Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, as well as pharmaceutical formulations. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b9591 crore,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"AARTIDRUGS Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170882,"url":"https:\/\/alphastreet.com\/india\/bharat-rasayan-q1-fy26-earnings-results\/","url_meta":{"origin":170918,"position":2},"title":"Bharat Rasayan Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"September 3, 2025","format":false,"excerpt":"Bharat Rasayan Ltd, incorporated in 1989, manufactures technical grade pesticides and intermediates used in the agrochemical industry. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b9377 crore, up 33.69% year-on-year (YoY) from \u20b9282 crore in Q1 FY25. Total Expenses: \u20b9315 crore, up 25.5% YoY from \u20b9251\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"BHARATRAS Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BRAS.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BRAS.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BRAS.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BRAS.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BRAS.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/BRAS.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169662,"url":"https:\/\/alphastreet.com\/india\/upl-ltd-q1-fy26-earnings-results-2-rise-in-revenue\/","url_meta":{"origin":170918,"position":3},"title":"UPL Ltd Q1 FY26 Earnings Results &#8211; 2% rise in Revenue","author":"Chirag Gupta","date":"August 1, 2025","format":false,"excerpt":"UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds. Presenting below are its Q1 FY26 earnings. Q1 FY26 Earnings Summary Consolidated Revenue:\u00a0\u20b99,216 crore, up 2% year-over-year (YoY) from \u20b99,067 crore in Q1 FY25. EBITDA:\u00a0\u20b91,303\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"UPL Ltd Q1 FY26 Earnings results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171150,"url":"https:\/\/alphastreet.com\/india\/deepak-nitrite-q1-fy26-earnings-results\/","url_meta":{"origin":170918,"position":4},"title":"Deepak Nitrite Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"September 11, 2025","format":false,"excerpt":"Deepak Nitrite Ltd, incorporated in 1970, manufactures basic intermediates, fine & specialty chemicals, performance products, and phenolics. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results: Revenue: \u20b91,890 crore, down 12.78% year-on-year YoY from \u20b92,167 crore Total Expenses: \u20b91,759 crore, down 7.95% YoY from \u20b91,911 crore Consolidated Net\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"DEEPAKNTR Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/NTR.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=170918"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170918\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/170919"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=170918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=170918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=170918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}